Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNiccolò Bolli, Nikhil C. Munshi, Hervé Avet‐Loiseau et al.|Nature Communications|2014Cited by 906
Identification of novel mutational drivers reveals oncogene dependencies in multiple myelomaBrian A. Walker, Gareth J. Morgan, Matthew Trotter et al.|Blood|2018Cited by 492
Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Susanna Jacobus et al.|New England Journal of Medicine|2022Cited by 457
A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysisBrian A. Walker, Gareth J. Morgan, Konstantinos Mavrommatis et al.|Leukemia|2018Cited by 452
Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myelomaMariateresa Fulciniti, Nikhil C. Munshi|Blood|2009Cited by 398